PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-04-27

Date Title Company
27-Apr-2023 Mainz Biomed to Commence Quarterly Reporting and Present at Equity Forum Spring Conference 2023 in Frankfurt, Germany Mainz BioMed N.V.
27-Apr-2023 MPH Health Care AG: Preliminary IFRS result 2022 MPH Health Care AG
27-Apr-2023 Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune Arix Bioscience plc
27-Apr-2023 BioSenic announces 2022 full-year results BioSenic
27-Apr-2023 Tiziana Life Sciences Ltd Reports Annual Results for the Twelve Months Ended December 31, 2022, and Corporate Update Tiziana Life Sciences
27-Apr-2023 BullFrog AI Partners with the Sage Group to Explore JV Opportunities to Advance its Oncology Assets BullFrog AI
27-Apr-2023 Bloomsbury Genetic Therapies Completes Successful Scientific Advice Meeting with the MHRA regarding its BGT-DTDS Program Bloomsbury Genetic Therapies Limited
27-Apr-2023 Nasal Spray Market Size – Industry Opportunities, Growth, Competitive Landscape, Recent Developments, Regional Outlook and Forecast by 2030 The Wire Times
27-Apr-2023 Defence Therapeutics Inc.: USPTO GRANTS TRADEMARK REGISTRATION FOR DEFENCE THERAPEUTICS® Defence Therapeutics Inc.
27-Apr-2023 Creative Proteomics Streamlines Your Drug Development Process with Its Peptide Characterization Service Creative Proteomics
27-Apr-2023 APONTIS PHARMA with first in-licensing of a Single Pill with two active ingredients for the primary prophylaxis of cardiovascular events - market launch already planned for early 2024 APONTIS PHARMA AG
27-Apr-2023 Formycon publishes results for financial year 2022 Formycon AG
27-Apr-2023 Kuros reports 168% increase in direct MagnetOs sales in the first quarter of 2023 Kuros Biosciences AG
27-Apr-2023 Xlife Sciences: Valuation Report 2022 confirms and emphasizes long-term portfolio potential Xlife Sciences AG
27-Apr-2023 Cell Therapy Manufacturing Market size is anticipated to reach a valuation of ~US$ 13.9 Billion by 2032, at a CAGR 14.2% from 2022 to 2032 MARKITWIRED
27-Apr-2023 Immunoassay Market demand analysis is expected to be worth USD 45.78 billion by 2032, at a CAGR 5% from 2022 to 2032 MARKITWIRED
27-Apr-2023 Alfa Chemistry Expresses Gratitude to Everyone Who Visited Its Booth at the ACS Spring 2023 Conference Alfa Chemistry
27-Apr-2023 CD Formulation Unveils Its Latest Offering: A Comprehensive Line of Pharmaceutical Formulation Characterization Testing Services CD Formulation